JPS6028998A - 心筋ミオシン重鎖に対する単一クロ−ン抗体 - Google Patents
心筋ミオシン重鎖に対する単一クロ−ン抗体Info
- Publication number
- JPS6028998A JPS6028998A JP58122579A JP12257983A JPS6028998A JP S6028998 A JPS6028998 A JP S6028998A JP 58122579 A JP58122579 A JP 58122579A JP 12257983 A JP12257983 A JP 12257983A JP S6028998 A JPS6028998 A JP S6028998A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- type
- cell
- cardiac
- myosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002107 myocardial effect Effects 0.000 title abstract description 6
- 108010044467 Isoenzymes Proteins 0.000 claims abstract description 13
- 230000000747 cardiac effect Effects 0.000 claims description 20
- 210000004408 hybridoma Anatomy 0.000 abstract description 28
- 230000001746 atrial effect Effects 0.000 abstract description 27
- 210000004027 cell Anatomy 0.000 abstract description 24
- 239000002609 medium Substances 0.000 abstract description 18
- 230000002861 ventricular Effects 0.000 abstract description 14
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract description 12
- 201000000050 myeloid neoplasm Diseases 0.000 abstract description 12
- 241000283690 Bos taurus Species 0.000 abstract description 8
- 208000010125 myocardial infarction Diseases 0.000 abstract description 8
- 239000006228 supernatant Substances 0.000 abstract description 8
- 210000004165 myocardium Anatomy 0.000 abstract description 7
- 210000000628 antibody-producing cell Anatomy 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 5
- 210000002966 serum Anatomy 0.000 abstract description 5
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 230000001575 pathological effect Effects 0.000 abstract description 2
- 229960005508 8-azaguanine Drugs 0.000 abstract 1
- 210000003754 fetus Anatomy 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 210000004989 spleen cell Anatomy 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 description 30
- 108010051609 Cardiac Myosins Proteins 0.000 description 13
- 102000013602 Cardiac Myosins Human genes 0.000 description 13
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 208000018578 heart valve disease Diseases 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 210000004102 animal cell Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 101000572820 Homo sapiens MICOS complex subunit MIC60 Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 102000005604 Myosin Heavy Chains Human genes 0.000 description 3
- 108010084498 Myosin Heavy Chains Proteins 0.000 description 3
- 241000233855 Orchidaceae Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 230000007910 cell fusion Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 102000046079 human IMMT Human genes 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 210000005265 lung cell Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000006152 selective media Substances 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000008934 Muscle Proteins Human genes 0.000 description 2
- 108010074084 Muscle Proteins Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 108010051583 Ventricular Myosins Proteins 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000003163 cell fusion method Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 210000003699 striated muscle Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 108010043797 4-alpha-glucanotransferase Proteins 0.000 description 1
- -1 4-aminoandibirine Chemical compound 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 108010084085 Atrial Myosins Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000700207 Mus macedonicus Species 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052713 technetium Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1075—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an enzyme
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58122579A JPS6028998A (ja) | 1983-07-06 | 1983-07-06 | 心筋ミオシン重鎖に対する単一クロ−ン抗体 |
| DE8484107663T DE3485965T2 (de) | 1983-07-06 | 1984-07-02 | Monoklonaler antikoerper mit spezifitaet gegen nur einen typ eines isozyms der schweren kette des menschlichen herzmyosins. |
| US06/626,918 US4767843A (en) | 1983-07-06 | 1984-07-02 | Monoclonal antibody to cardiac myosin heavy chain |
| EP84107663A EP0131834B1 (en) | 1983-07-06 | 1984-07-02 | Monoclonal antibody having specificity to only one type of an isozyme of human cardiac myosin heavy chain |
| AU30228/84A AU570696B2 (en) | 1983-07-06 | 1984-07-03 | Monoclonal antibody to cardiac myosin heavy chain |
| KR1019840003916A KR910008637B1 (ko) | 1983-07-06 | 1984-07-06 | 심근 미오신 중사슬에 대한 단일클론항체 |
| CA000458361A CA1225608A (en) | 1983-07-06 | 1984-07-06 | Monoclonal antibody to cardiac myosin heavy chain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58122579A JPS6028998A (ja) | 1983-07-06 | 1983-07-06 | 心筋ミオシン重鎖に対する単一クロ−ン抗体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1319321A Division JPH02219596A (ja) | 1989-12-09 | 1989-12-09 | 心筋ミオシン重鎖に対する単一クローン抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6028998A true JPS6028998A (ja) | 1985-02-14 |
| JPH0231958B2 JPH0231958B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-07-17 |
Family
ID=14839400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58122579A Granted JPS6028998A (ja) | 1983-07-06 | 1983-07-06 | 心筋ミオシン重鎖に対する単一クロ−ン抗体 |
Country Status (7)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990011520A1 (fr) * | 1989-03-28 | 1990-10-04 | Yamasa Shoyu Kabushiki Kaisha | Anticorps contre une chaine lourde de myosine des muscles lisses |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60201260A (ja) * | 1984-03-27 | 1985-10-11 | Yamasa Shoyu Co Ltd | 心疾患診断薬 |
| JPH0625762B2 (ja) * | 1985-06-13 | 1994-04-06 | ヤマサ醤油株式会社 | ミオシン軽鎖の測定法 |
| GB2200358B (en) * | 1987-01-27 | 1991-02-27 | Univ Birmingham | Materials for in vivo detection of cardiac damage, and methods for their preparation |
| US5046499A (en) * | 1988-06-13 | 1991-09-10 | Centocor, Inc. | Method for myocardial infarct risk assessment |
| US5830720A (en) * | 1989-04-21 | 1998-11-03 | Boehringer Mannheim Gmbh | Recombinant DNA and expression vector for the repressible and inducible expression of foreign genes |
| US5364612A (en) * | 1991-05-06 | 1994-11-15 | Immunomedics, Inc. | Detection of cardiovascular lesions |
| AU691675B2 (en) * | 1994-10-25 | 1998-05-21 | Yamasa Corporation | Antibody reagent for detecting dissecting aortic aneurysm and use thereof |
| JP4035167B2 (ja) * | 1996-02-19 | 2008-01-16 | ヤマサ醤油株式会社 | 血管障害性疾患用診断薬 |
| US6248869B1 (en) | 1997-05-29 | 2001-06-19 | Medical Analysis Systems, Inc. | Troponin I forms and use of the same |
-
1983
- 1983-07-06 JP JP58122579A patent/JPS6028998A/ja active Granted
-
1984
- 1984-07-02 DE DE8484107663T patent/DE3485965T2/de not_active Expired - Fee Related
- 1984-07-02 EP EP84107663A patent/EP0131834B1/en not_active Expired
- 1984-07-02 US US06/626,918 patent/US4767843A/en not_active Expired - Lifetime
- 1984-07-03 AU AU30228/84A patent/AU570696B2/en not_active Ceased
- 1984-07-06 CA CA000458361A patent/CA1225608A/en not_active Expired
- 1984-07-06 KR KR1019840003916A patent/KR910008637B1/ko not_active Expired
Non-Patent Citations (1)
| Title |
|---|
| THE JOURNAL OF BIOIOGICAL CHEMISTRY * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990011520A1 (fr) * | 1989-03-28 | 1990-10-04 | Yamasa Shoyu Kabushiki Kaisha | Anticorps contre une chaine lourde de myosine des muscles lisses |
Also Published As
| Publication number | Publication date |
|---|---|
| AU3022884A (en) | 1985-01-10 |
| DE3485965T2 (de) | 1993-03-18 |
| EP0131834A2 (en) | 1985-01-23 |
| DE3485965D1 (de) | 1992-12-03 |
| EP0131834B1 (en) | 1992-10-28 |
| KR850001282A (ko) | 1985-03-18 |
| JPH0231958B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-07-17 |
| US4767843A (en) | 1988-08-30 |
| AU570696B2 (en) | 1988-03-24 |
| EP0131834A3 (en) | 1987-06-24 |
| KR910008637B1 (ko) | 1991-10-19 |
| CA1225608A (en) | 1987-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5047507A (en) | Monoclonal antibodies with specificity affinity for human carcinoembryonic antigen | |
| JPH0811075B2 (ja) | 単クローン性抗ｃｅａ抗体 | |
| JPS5929622A (ja) | モノクロ−ナル抗体、その製造法およびその用途 | |
| JP3673522B2 (ja) | 抗アネキシンｖモノクローナル抗体並びにその利用及びそれを産生するハイブリドーマ細胞系 | |
| JPS6028998A (ja) | 心筋ミオシン重鎖に対する単一クロ−ン抗体 | |
| EP0163141B1 (en) | Monoclonal anti-human igg antibody and process for preparing the same | |
| JPS59192092A (ja) | レジオネラに対する抗体を生成する交雑ネズミ細胞系およびその製造方法、並びにモノクロナ−ル抗体 | |
| EP0142345A2 (en) | Anti-idiotypic vaccine employing anti-idiotypic monoclonal antibodies | |
| ES2459290T3 (es) | Anticuerpos monoclonales para la determinación inmunológica selectiva de formas de lamininas de alto peso molecular en líquidos corporales | |
| US5206007A (en) | Anti-human myocardial c protein monoclonal antibody and hybridoma producing the antibody | |
| CA1238285A (en) | Monoclonal antibody specific for a mammary tumor cytoplasmis antigen | |
| EP0575906A2 (en) | Sandwich immunoassay of beta-N-acetylglucosaminidase and monoclonal antibody used therein | |
| EP0205352A2 (en) | Monoclonal anti-human IgG4 antibodies, their production and use | |
| DE3633323A1 (de) | Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega | |
| JPH02211896A (ja) | ミオシン軽鎖に対するモノクローナル抗体 | |
| JPH0320240B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JPS6042400A (ja) | ヒトＩｇＭに対する単一クロ−ン抗体 | |
| JPH1175839A (ja) | モノクローナル抗体、細胞株及びｎ１，ｎ１２−ジアセチルスペルミンの測定法 | |
| JPH05176790A (ja) | 脳ミオシンに対するモノクローナル抗体 | |
| JP3036545B2 (ja) | モノクローナル抗体とこれを産生するハイブリドーマ細胞株、およびこれを用いる免疫学的測定法 | |
| FI93469C (fi) | Menetelmä hybridoomasolulinjan ja sen tuottaman vasta-aineen tuottamiseksi | |
| JPS63209596A (ja) | モノクロ−ナル抗体及びその使用方法 | |
| JPS60253871A (ja) | 抗アポａ−１抗体 | |
| JPS61126100A (ja) | 抗ＴｄＴモノクロ−ナル抗体及びその製造法 | |
| JPS63240798A (ja) | 抗ヒト癌モノクローナル抗体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |